Bluestem Group Inc. provided earnings guidance for the full year of 2016. The company is projecting total net sales for the year to be between $2.05 billion and $2.15 billion. This would represent a year-over-year decline in net sales of between 6% and 2%. The company expects full-year adjusted EBITDA to be between $130 million and $140 million. This is obviously down from last year's pro forma adjusted EBITDA previously disclosed of roughly $160 million. The company expects CapEx projection for the year of $19 million to $23 million.